State Street
GOSS icon

State Street’s Gossamer Bio GOSS Stock Holding History

State Street’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Sell
1,114,718
-3,273,391
-75% -$914K ﹤0.01% 3855
2026
Q1 		$1.44M Sell
4,388,109
-4,922,860
-53% -$7.74M ﹤0.01% 3396
2025
Q4 		$28.9M Buy
9,310,969
+5,427,302
+140% +$15.5M ﹤0.01% 2052
2025
Q3 		$10.2M Buy
3,883,667
+1,402,261
+57% +$3.09M ﹤0.01% 2632
2025
Q2 		$3.05M Buy
2,481,406
+1,598,730
+181% +$1.74M ﹤0.01% 3156
2025
Q1 		$971K Buy
882,676
+114,200
+15% +$132K ﹤0.01% 3432
2024
Q4 		$695K Buy
768,476
+55,700
+8% +$47.7K ﹤0.01% 3557
2024
Q3 		$703K Hold
712,776
– – ﹤0.01% 3534
2024
Q2 		$642K Buy
712,776
+23,525
+3% +$17.6K ﹤0.01% 3536
2024
Q1 		$813K Sell
689,251
-24,300
-3% -$26.7K ﹤0.01% 3519
2023
Q4 		$651K Buy
713,551
+383,400
+116% +$283K ﹤0.01% 3582
2023
Q3 		$275K Sell
330,151
-14,600
-4% -$16.8K ﹤0.01% 3842
2023
Q2 		$414K Sell
344,751
-978,746
-74% -$1.22M ﹤0.01% 3740
2023
Q1 		$1.67M Sell
1,323,497
-26,520,488
-95% -$50.8M ﹤0.01% 3394
2022
Q4 		$60.4M Buy
27,843,985
+24,066,082
+637% +$198M ﹤0.01% 1503
2022
Q3 		$45.3M Sell
3,777,903
-97,291
-3% -$1.21M ﹤0.01% 1653
2022
Q2 		$32.4M Buy
3,875,194
+567,264
+17% +$4.4M ﹤0.01% 1918
2022
Q1 		$28.7M Buy
3,307,930
+15,839
+0.5% +$153K ﹤0.01% 2139
2021
Q4 		$37.2M Buy
3,292,091
+629,325
+24% +$7.48M ﹤0.01% 2020
2021
Q3 		$33.5M Sell
2,662,766
-664,950
-20% -$6.12M ﹤0.01% 2103
2021
Q2 		$27M Sell
3,327,716
-537,965
-14% -$4.66M ﹤0.01% 2318
2021
Q1 		$35.8M Buy
3,865,681
+1,134,827
+42% +$11.4M ﹤0.01% 1984
2020
Q4 		$26.4M Buy
2,730,854
+575,865
+27% +$5.67M ﹤0.01% 2066
2020
Q3 		$26.7M Buy
2,154,989
+254,417
+13% +$3.37M ﹤0.01% 1865
2020
Q2 		$24.7M Buy
1,900,572
+241,674
+15% +$3.04M ﹤0.01% 1920
2020
Q1 		$16.8M Buy
1,658,898
+13,649
+0.8% +$178K ﹤0.01% 1949
2019
Q4 		$25.7M Buy
1,645,249
+897,311
+120% +$18.1M ﹤0.01% 1965
2019
Q3 		$12.6M Buy
747,938
+400,491
+115% +$7.96M ﹤0.01% 2348
2019
Q2 		$7.71M Buy
347,447
+194,766
+128% +$3.73M ﹤0.01% 2610
2019
Q1 		$3.31M Buy
+152,681
New +$3.18M ﹤0.01% 2946

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

State Street's GOSS Position: Q2 2026 in Review

State Street reduced its Gossamer Bio (GOSS) stake by 75% in Q2 2026, selling an estimated $914K and leaving 1,114,718 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #3855.

State Street first reported a position in GOSS in Q1 2019 and has held it in 30 quarters since. The position peaked at $60.4M in Q4 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • State Street held 1,114,718 shares of Gossamer Bio worth $183K as of Q2 2026.
  • State Street sold 3,273,391 Gossamer Bio shares in Q2 2026, an estimated $914K.
  • Gossamer Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3855 holding.
  • State Street first reported a position in Gossamer Bio in Q1 2019 and has held it in 30 quarters since.
  • State Street's Gossamer Bio position peaked at $60.4M in Q4 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.